Brookfield Asset Management Inc. Novartis Ag Transaction History

Brookfield Asset Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $11.8 Million - $14.5 Million	-156,776 Reduced 80.09%	38,968 $3.54 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $6.76 Million - $7.9 Million	90,571 Added 86.12%	195,744 $14.9 Million
Q2 2022 Nov 16, 2022	SELL	$80.52 - $93.75 $7.29 Million - $8.49 Million	-90,571 Reduced 46.27%	105,173 $8.89 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $8.47 Million - $9.86 Million	105,173 New	105,173 $8.89 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.